11-93821144-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001144871.2(VSTM5):c.271C>A(p.Gln91Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000432 in 1,552,184 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144871.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSTM5 | NM_001144871.2 | c.271C>A | p.Gln91Lys | missense_variant | 2/4 | ENST00000409977.2 | NP_001138343.1 | |
VSTM5 | XR_001747865.2 | n.387C>A | non_coding_transcript_exon_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSTM5 | ENST00000409977.2 | c.271C>A | p.Gln91Lys | missense_variant | 2/4 | 5 | NM_001144871.2 | ENSP00000386607 | P1 | |
VSTM5 | ENST00000414919.2 | n.930C>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152198Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000758 AC: 12AN: 158276Hom.: 0 AF XY: 0.0000719 AC XY: 6AN XY: 83500
GnomAD4 exome AF: 0.0000429 AC: 60AN: 1399868Hom.: 0 Cov.: 31 AF XY: 0.0000449 AC XY: 31AN XY: 690422
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.271C>A (p.Q91K) alteration is located in exon 2 (coding exon 2) of the VSTM5 gene. This alteration results from a C to A substitution at nucleotide position 271, causing the glutamine (Q) at amino acid position 91 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at